Awareness and use of lipid guidelines among respondents
| Awareness and use of lipid guidelines | n (%) |
|---|---|
| Awareness of Malaysian CPG on management of dyslipidaemia (n=465) | |
| Yes | 456 (98.1) |
| No | 9 (1.9) |
| Awareness of AHA guideline on treatment of blood cholesterol (n=463) | |
| Yes | 364 (78.6) |
| No | 99 (21.4) |
| Use any lipid guidelines. (n=460) | |
| Yes | 440 (95.6) |
| No | 20 (4.4) |
| Guidelines use (participants can choose more than one) (n=466) | |
| Malaysian CPG | 429 (92.1) |
| AHA guideline* | 87 (18.7) |
| ATP III guideline† revised 2008 | 11 (2.4) |
| NICE guideline‡ 2008 | 42 (9.0) |
| Others§ | 1 (0.2) |
*American Heart Association (AHA) guideline 2013 on the treatment of blood cholesterol to reduce Atherosclerotic Cardiovascular Disease (ASCVD) risk.
†Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2008.
‡National Institute for Health and Clinical Excellence (NICE) guideline on lipid modification 2008.
§The participant did not specify the guideline used.
ATP, Advance in Primary Care Training Programme; CPG, Clinical Practice Guideline.